Tracy Sherertz
Papers
1
Total Citations
28
H-Index
1
About
Tracy Sherertz is a radiation oncologist whose research focuses on integrating advanced radiotherapy techniques with systemic therapies for gynecologic cancers. Her work centers on stereotactic ablative radiotherapy (SABR) for persistent or recurrent disease, particularly exploring how to safely combine this precise, high-dose radiation with chemotherapy. In her notable Phase I trial (28 citations), she established the safety of administering carboplatin and gemcitabine chemotherapy prior to abdominopelvic SABR, providing a critical foundation for palliative treatment strategies in women with limited options. This contribution helps define dose-limiting toxicities and treatment protocols for this challenging patient population. Sherertz’s research addresses a vital need: improving local control and quality of life for those with recurrent gynecologic malignancies. Her work at the intersection of radiation oncology and medical oncology demonstrates a commitment to developing tolerable, effective combination regimens, making her a key voice in advancing palliative care for gynecologic cancer patients.
Research Focus
Key Achievements
Top Papers
- 1